Evidence map›Paper›PMID 26660890›Full record

ArticleDiabetologia2016

Disruption of calcium transfer from ER to mitochondria links alterations of mitochondria-associated ER membrane integrity to hepatic insulin resistance.

Jennifer Rieusset, Jeremy Fauconnier, Melanie Paillard, Elise Belaidi, Emily Tubbs, Marie-Agnès Chauvin, Annie Durand, Amélie Bravard, Geoffrey Teixeira, Birke Bartosch and 10 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Diabetologia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 160 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 1 country.

Jennifer RieussetInserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France. jennifer.rieusset@univ-lyon1.fr.
Jeremy FauconnierInserm U1046-CNRS UMR-9214, PhyMedExp, Université Montpellier, Montpellier, France.
Melanie PaillardInserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France.
Elise BelaidiInserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France.
Emily TubbsInserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France.
Marie-Agnès ChauvinInserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France.
Annie DurandInserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France.
Amélie BravardInserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France.
Geoffrey TeixeiraInserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France.
Birke BartoschInserm UMR-1052, Centre de recherche en Cancérologie de Lyon, Université Lyon 1, Lyon, France.
Maud MicheletInserm UMR-1052, Centre de recherche en Cancérologie de Lyon, Université Lyon 1, Lyon, France.
Pierre TheureyInserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France.
Guillaume VialInserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France.
Marie DemionInserm U1046-CNRS UMR-9214, PhyMedExp, Université Montpellier, Montpellier, France.
Emilie BlondInserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France.
Fabien ZoulimInserm UMR-1052, Centre de recherche en Cancérologie de Lyon, Université Lyon 1, Lyon, France.
Ludovic GomezInserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France.
Hubert VidalInserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France.
Alain LacampagneInserm U1046-CNRS UMR-9214, PhyMedExp, Université Montpellier, Montpellier, France.
Michel OvizeInserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France.
Inserm · FRLaboratoire CarMeN · FRUniversité Claude Bernard Lyon 1 · FRHospices Civils de Lyon · FRUniversité de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aims/hypothesisMitochondria-associated endoplasmic reticulum membranes (MAMs) are regions of the endoplasmic reticulum (ER) tethered to mitochondria and controlling calcium (Ca(2+)) transfer between both organelles through the complex formed between the voltage-dependent anion channel, glucose-regulated protein 75 and inositol 1,4,5-triphosphate receptor (IP3R). We recently identified cyclophilin D (CYPD) as a new partner of this complex and demonstrated a new role for MAMs in the control of insulin's action in the liver. Here, we report on the mechanisms by which disruption of MAM integrity induces hepatic insulin resistance in CypD (also known as Ppif)-knockout (KO) mice.

methodsWe used either in vitro pharmacological and genetic inhibition of CYPD in HuH7 cells or in vivo loss of CYPD in mice to investigate ER-mitochondria interactions, inter-organelle Ca(2+) exchange, organelle homeostasis and insulin action.

resultsPharmacological and genetic inhibition of CYPD concomitantly reduced ER-mitochondria interactions, inhibited inter-organelle Ca(2+) exchange, induced ER stress and altered insulin signalling in HuH7 cells. In addition, histamine-stimulated Ca(2+) transfer from ER to mitochondria was blunted in isolated hepatocytes of CypD-KO mice and this was associated with an increase in ER calcium store. Interestingly, disruption of inter-organelle Ca(2+) transfer was associated with ER stress, mitochondrial dysfunction, lipid accumulation, activation of c-Jun N-terminal kinase (JNK) and protein kinase C (PKC)ε and insulin resistance in liver of CypD-KO mice. Finally, CYPD-related alterations of insulin signalling were mediated by activation of PKCε rather than JNK in HuH7 cells. CONCLUSIONS/

interpretationDisruption of IP3R-mediated Ca(2+) signalling in the liver of CypD-KO mice leads to hepatic insulin resistance through disruption of organelle interaction and function, increase in lipid accumulation and activation of PKCε. Modulation of ER-mitochondria Ca(2+) exchange may thus provide an exciting new avenue for treating hepatic insulin resistance.

Indexed as

AnimalsCalciumCell LineCyclophilinsEndoplasmic ReticulumHepatocytesHumansInositol 1,4,5-Trisphosphate ReceptorsInsulin ResistanceLiverMaleMiceMice, KnockoutMitochondriaPeptidyl-Prolyl Isomerase FCalciumCyclophilinsInositol 1,4,5-Trisphosphate ReceptorsPeptidyl-Prolyl Isomerase FPPIF protein, mouseCalcium signallingCyclophilin DEndoplasmic reticulumInositol 1,4,5-triphosphate receptorInsulin resistanceLiverMitochondriaMitochondria-associated endoplasmic reticulum membranesPKCε

Identifiers

PMID26660890
OpenAlexW2291464422

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.